Molina Healthcare (MOH) PT Raised to $161 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts MOH Hot Sheet
Price: $226.42 --0%
Rating Summary:
11 Buy, 19 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 31 | New: 5
Rating Summary:
11 Buy, 19 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 31 | New: 5
Join SI Premium – FREE
Barclays analyst Andrew Mok raised the price target on Molina Healthcare (NYSE: MOH) to $161.00 (from $133.00) while maintaining a Underweight rating.
The analyst commented, "Revising PT: We maintain our 2026 and 2027 EPS estimates and raise our PT from $133 to $161 on a higher 12x P/E (was 11x) on our 2027 EPS to reflect signs of stabilization in the Medicaid business and encouraging underlying cost trends."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Upgrades Joby Aviation Inc (JOBY) to Buy
- BofA Securities Double Downgrades LegalZoom.com Inc (LZ) to Underperform
- 1stdibs.Com, Inc. (DIBS) Tops Q3 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Barclays, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
